Appearance | White to Almost white powder to crystal |
Purity(HPLC) | 99.94% |
Purity(Neutralization titration) | min. 98.0 % |
Specific rotation [a]20/D | -26.0 to -30.0 deg(C=0.34, H2O) |
NMR | confirm to structure |
Didanosine
2′,3′-Dideoxyinosine; 9-(2,3-Dideoxy-β-D-ribofuranosyl)-6-oxopurine; 9-(2,3-Dideoxy-β-D-ribofuranosyl)hypoxanthine
Purity / Analysis Method | >98.0%(HPLC) |
Molecular Formula / Molecular Weight | C10H12N4O3 = 236.23 |
Physical State (20 deg.C) | Solid |
CAS RN | 69655-05-6 |
Unit | Price |
500 mg | 7500 |
1 g | 13950 |
5 g | 19950 |
Note | • Pharmaceutical Ingredients (for Research and Experimental Use) is provided as delivered and specified by the issuing Pharmacopoeia. |
---|